Trevi Therapeutics
TRVI
#7459
Rank
A$0.55 B
Marketcap
$6.18
Share price
-0.77%
Change (1 day)
160.38%
Change (1 year)

Earnings for Trevi Therapeutics (TRVI)

Earnings in 2024 (TTM): -A$65.84 Million

According to Trevi Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -A$45.72 Million a decrease over its 2022 earnings that were of -A$44.63 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Trevi Therapeutics from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$65.84 Million44.02%
2023 -A$45.72 Million2.43%
2022 -A$44.63 Million-14.45%
2021 -A$52.17 Million1.36%
2020 -A$51.47 Million23.64%
2019 -A$41.63 Million27.54%
2018 -A$32.64 Million